It's the sixth leading cause of death in the United States, with no existing cure. But these researchers are committed to finding better ways to diagnose, treat and prevent the debilitating disease, using everything from innovative biomarker tracking to a potential vaccine for early stage patients.
In honor of Martin Luther King Jr. Day, Johnson & Johnson’s Chief Diversity & Inclusion Officer, Wanda Bryant Hope, shares what it was like for her mother to fight for equal rights in the 1960s.
Cancer. Alzheimer’s. Even suicide risk. The clues to preventing these and other conditions could be found in our DNA—and these scientists are at the forefront of promising new genetic data research to uncover them.
Brilliant, outside-the-box ideas to help people live without illness as they live longer. That's what Johnson & Johnson and the National Academy of Medicine are looking for through a unique collaboration—and they’re putting up millions of dollars in prize money to find them.
From robotics solutions for orthopedic surgery to the potential to bring new hope to patients living with multiple myeloma through CAR-T, these are just some of the cutting-edge projects that these visionaries think could potentially help propel healthcare forward around the globe.
Alex Tait / Jelly London
From a promising alternative for the flu shot to hope for a "universal" vaccine, we take a look at how scientists at Johnson & Johnson are exploring novel ideas for preventing and treating the flu.

Recent Johnson & Johnson Initiatives in the Spotlight

Learn more about the company’s latest groundbreaking programs, game-changing innovations and global partnerships—all aimed at helping change the trajectory of health for humanity.
This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue